Compile Data Set for Download or QSAR
Report error Found 63 Enz. Inhib. hit(s) with all data for entry = 3051
TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM303544(US10138229, Example 55 | US9951056, Example 12 | U...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389637(US9951056, Example 11 | 1-(1-acryloylpiperidin-3-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389636(US9951056, Example 10 | 6-(3-acrylamidopyrrolidin-...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389635(US9951056, Example 8 | 6-(1-acryloylpiperidin-3-yl...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389644(US9951056, Example 17 | 1-(3-aminophenyl)-3-(4-phe...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389643(US9951056, Example 16 | 1-(4-acrylamidophenyl)-3-(...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389642(US9951056, Example 15 | 1-(1-acryloylazetidin-3-yl...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389641(US9951056, Example 13 | 1-(1-acryloylpyrrolidin-3-...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389630(US9951056, Example 1 | 6-(3-acrylamidophenyl)-2-(4...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389634(US9951056, Example 7 | 6-(4-acrylamidophenyl)-2-(4...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389633(6-(1-acryloylpyrrolidin-3-yl)-2-(4-phenoxyphenyl)n...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389632(US9951056, Example 5 | 6-(4-acryloylpiperazin-1-yl...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389631(US9951056, Example 3 | 6-(1-acryloylpiperidin-4-yl...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389656(US9951056, Example 34 | 1-(1-(4-(dimethylamino)but...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389655(US9951056, Example 32 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389654(US9951056, Example 29 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389653(US9951056, Example 28 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389660(US9951056, Example 38 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389659(US9951056, Example 37 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389658(US9951056, Example 36 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389657(US9951056, Example 35 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389648(US9951056, Example 21 | 2-(1-acryloylpiperidin-4-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389647(US9951056, Example 20 | (R)-1-(1-acryloylpyrrolidi...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389646(US9951056, Example 19 | (S)-1-(1-acryloylpyrrolidi...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389645(US9951056, Example 18 | 1-(3-acrylamidophenyl)-3-(...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389652(US9951056, Example 26 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389651(US9951056, Example 25 | (E)-6-(4-(4-(dimethylamino...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389633(6-(1-acryloylpyrrolidin-3-yl)-2-(4-phenoxyphenyl)n...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389649(US9951056, Example 22 | 2-(1-acryloylpyrrolidin-3-...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389672(US9951056, Example 51 | 2-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389671(US9951056, Example 49 | 2-(1-acryloylpiperidin-4-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389670(US9951056, Example 48 | 2-(1-acryloylpyrrolidin-3-...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389669(US9951056, Example 47 | 2-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389676(US9951056, Example 57 | 5-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389675(US9951056, Example 55 | 5-(1-acryloylpiperidin-4-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389674(US9951056, Example 54 | 2-(1-acryloylpiperidin-3-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389673(US9951056, Example 52 | 2-(1-acryloylpiperidin-4-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389664(US9951056, Example 42 | 2-(1-acryloylpiperidin-3-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389663(US9951056, Example 41 | 2-(1-acryloylpyrrolidin-3-...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389662(US9951056, Example 40 | 2-(1-acryloylpiperidin-3-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389661(US9951056, Example 39 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389668(US9951056, Example 46 | 2-(1-acryloylpiperidin-4-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389667(US9951056, Example 45 | 2-(1-acryloylpiperidin-3-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389666(US9951056, Example 44 | 2-(1-acryloylpyrrolidin-3-...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389665(US9951056, Example 43 | 2-(1-acryloylpyrrolidin-3-...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389681(US9951056, Example 61 | 6-(1-acryloylpiperidin-4-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389680(US9951056, Example 60 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389679(US9951056, Example 59 | (E)-1-(1-(2-cyanobut-2-eno...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM389678(US9951056, Example 58 | 6-(1-acryloylpiperidin-4-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM390425(US9951056, Example 63 | 2-(4-phenoxyphenyl)-6-(1-(...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
Go to US Patent

Displayed 1 to 50 (of 63 total ) | Next | Last >>
Jump to: